Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Abbott
With
Fraktal.com.pl
Med-net.pl
The remaining target is:
\- to assess the intensity of LUTS in Polish and Ukrainian patients with locally advanced and metastatic prostate cancer, previously untreated with hormonal therapy
Presence of lower urinary tract symptoms (LUTS)-IPSS \>0
Treatment with Lucrin® Depot is the routine therapy in the patient. The decision as to Lucrin® Depot choice will not be associated with patient's participation in the study, but will result from the best medical knowledge and practice.
Until inclusion into PMOS the patient has not been treated with GnRH analogue.
The patient, before inclusion into the study, has not been treated by surgery (radical prostatectomy).
You may not be if
Patients will not be included into the study if any contraindications to treatment with Lucrin® Depot exist, or if there are other treatment options which, according to the present medical knowledge, are potentially more beneficial for the patient.
Physician or patient can stop treatment at any moment, if any indications or reasons exist.
Clareo Health | Lucrin® Depot Efficacy and Safety Monitoring Study in Patients With Advanced Prostate Cancer and Lower Urinary Tract Symptoms (LUTS)
